[1]
K. Tshering and M. Misbahuddin, “In silico prediction of telomerase reverse transcriptase inhibitors using modified retinol for the treatment of arsenical cancer”, Bangabandhu Sheikh Mujib Medical University Journal, vol. 9, no. 3, pp. 164–168, Sep. 2016.